The dose of oral hypoglycemic agents or insulin was reduced in 5 participants by their diabetes care providers, 4 participants’ insulin prescriptions were reduced by 6 to 24 units and 1 participant’s oral hyperglycemic agent prescription was reduced to a smaller dose. The gene discussed is INS; the disease is diabetes mellitus.